WinRho SDF

Indicated For

Immune Thrombocytopenic Purpura (ITP), Rh incompatibility

About This Medication

# NABI Reimbursement Program for WinRho Patient Guide: How to Get WinRho SDF at Low or No Cost WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)) is a specialized medication used to treat immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, leading to low platelet counts and increased bleeding risk. The **NABI Reimbursement Program for WinRho**, offered by **NABI (Nabi Biopharmaceuticals)**, helps eligible patients access this drug at low or no cost by covering expenses for those who qualify based on income and lack of insurance coverage.[1] ## About WinRho SDF **WinRho SDF** is indicated for non-splenectomized, Rh o(D)-positive patients needing to raise platelet counts to prevent excessive bleeding. It treats: - Children with chronic or acute ITP - Adults with chronic ITP - Children and adults with ITP secondary to HIV infection[1][7] Administered intravenously (IV) over 3-5 minutes, it's available in vials like 1500 IU (300 mcg), 2500 IU (500 mcg), and others. Dosing is weight-based, e.g., 250 IU/kg (50 mcg/kg) initially, with monitoring of platelet counts, hemoglobin (Hgb), and other labs post-infusion. Patients must have Hgb ≥8 g/dL; reduced doses apply for Hgb 8-10 g/dL. It's often used as bridge therapy when switching treatments.[3][6][7] **Important Safety Note**: Monitor for intravascular hemolysis (IVH) for at least 8 hours after infusion. Ensure patients are not volume-depleted, and use caution in those at risk for renal issues.[1][3] ## Who Qualifies for the NABI Reimbursement Program? This program targets patients facing financial barriers to WinRho SDF. Key eligibility: - **Medical Need**: Prescription for WinRho SDF to treat eligible ITP conditions. - **Income Limits**: Household income at or below **200% of the Federal Poverty Level (FPL)**. No specific thresholds listed for individual, couple, family of 3, or 4—use 200% FPL guidelines. - **Insurance Status**: Patients **without prescription coverage**, including those with **Medicare Part D**.[program data] ### Income Eligibility Breakdown Use the U.S. Department of Health & Human Services (HHS) FPL guidelines (updated annually). Here's a sample table for 2026 (check current at aspe.hhs.gov/poverty-guidelines for exact figures): | Household Size | 100% FPL | 200% FPL (Eligibility Max) | |---------------|----------|----------------------------| | 1 | $15,060 | **$30,120** | | 2 | $20,440 | **$40,880** | | 3 | $25,820 | **$51,640** | | 4 | $31,200 | **$62,400** | *Add ~$5,380 per additional person for 100% FPL, double for 200%. Income includes all sources; deductions may apply.*[program data] ## Insurance Requirements The program is for uninsured patients or those lacking prescription drug coverage. It explicitly includes **Medicare Part D enrollees** without adequate coverage for WinRho. If you have private insurance, commercial plans, or other coverage that pays for WinRho, you may not qualify. Contact the program to confirm.[program data][1] ## Step-by-Step Application Process The program supports **multiple application methods** for flexibility. While specific forms aren't listed, follow these general steps based on standard PAP processes and manufacturer contacts:[program data][1][2] 1. **Get a Prescription**: Ask your doctor to prescribe WinRho SDF and discuss if you qualify for assistance. 2. **Check Eligibility**: Verify income ≤200% FPL and no prescription coverage. Gather proof. 3. **Contact the Program**: Call **Customer Service at 1-833-779-2614** (toll-free) or email **gmb-sps-kamada@cardlogistics.com** for forms, guidance, and reimbursement questions. Mention 'NABI Reimbursement Program'.[1] 4. **Complete Application**: Applications available via phone/email or download from sites like PrescriberPoint.[2] Provide: - Proof of income (tax returns, pay stubs, etc.)—**no specific documents mandated, but standard proofs required**.[program data] - Proof of no prescription insurance. - Doctor's prescription and medical records confirming ITP diagnosis. - Patient ID info. 5. **Submit**: Fax, mail, or upload as instructed. Your doctor/pharmacy may handle reimbursement claims using J-code **J2792**.[1] 6. **Follow Up**: Track status via contact number. ## Timeline and Delivery **Processing time** not specified—typically 2-4 weeks for PAPs, but call for updates. Once approved, WinRho is ordered via major wholesalers (e.g., McKesson, Cardinal) using NDC codes like 49591-330-51. **Delivery method** varies; often shipped to your pharmacy, doctor's office, or home. Infusion occurs IV in a clinical setting—**not self-administered**.[1][3] ## Alternatives if Denied or Biosimilars If denied (e.g., income too high or insured), consider: - **Biosimilar Alternatives**: **Hyperrho** or **Rhophylac**—similar Rho(D) immune globulins for ITP.[program data] - Other PAPs or copay cards via PrescriberPoint.[2] - Ryan White programs for HIV-related ITP.[4] - VA formulary if eligible.[5] - Doctor may suggest other ITP treatments like steroids or splenectomy. ## Disclaimer This guide is for informational purposes only and based on available program data as of 2026. Eligibility, terms, and contacts can change—**always verify directly with NABI at 1-833-779-2614 or gmb-sps-kamada@cardlogistics.com**. Not medical advice; consult your doctor for treatment. WinRho has risks like IVH, renal issues—review full safety info.[1][6] Word count: 950.

Program information last verified: March 30, 2026